GSK Pharma Q1 profit at Rs 88.59 crore Ruby Khatun Khatun26 July 2018 10:10 AM ISTNew Delhi: GlaxoSmithKline Pharmaceuticals (GSK) reported a standalone net profit of Rs 88.59 crore for the first quarter of the current fiscal.It had...
FDA panel votes against approval of GSK's lung disease drug Ruby Khatun Khatun26 July 2018 9:45 AM ISTWASHINGTON: A U.S. Food and Drug Administration expert panel on Wednesday did not support approval of GlaxoSmithKline Plc’s (GSK) drug Nucala in...
China launches nationwide vaccine sector inspection after scandal Ruby Khatun Khatun26 July 2018 9:30 AM ISTBeijing: China's drug regulator said it has launched a nationwide inspection of vaccine production as authorities step up the response to a fraud case...
Not a Single Case of bad quality generic medicines in India: Minister tells Lok Sabha Ruby Khatun Khatun25 July 2018 5:10 PM ISTNew Delhi: Despite countless allegations that generic medicines that are being sold in the country lack any control and hence are of poor quality,...
Ceiling of drug prices helped save Rs 11,463 crore to public: Govt Ruby Khatun Khatun25 July 2018 10:30 AM ISTNew Delhi: The government said fixation of ceiling prices of medicines has resulted in a saving of Rs 11,463 crore to the public after the...
Alkem Labs gets EIR from USFDA for its Daman facility Ruby Khatun Khatun25 July 2018 10:15 AM ISTNew Delhi: Drug firm Alkem Laboratories said the US health regulator has issued an establishment inspection report (EIR) for its Daman...
Granules India Q1 net profit up 41 percent to Rs 51.7 crore Ruby Khatun Khatun25 July 2018 10:00 AM ISTNew Delhi: Drug firm Granules India reported a 40.73 percent rise in its consolidated net profit at Rs 51.79 crore for the quarter ended on June 30,...
Eisai, Biogen to advance Alzheimer's drug, provide fresh hope Ruby Khatun Khatun25 July 2018 9:45 AM ISTEisai Co Ltd and Biogen Inc will move forward with late-stage clinical trials of their Alzheimer's disease drug, BAN2401, and are working with...
GSK's two-drug HIV treatment proves itself in key tests Ruby Khatun Khatun25 July 2018 9:30 AM ISTLONDON: GlaxoSmithKline's (GSK) simple two-drug treatment for HIVworks as well as standard triple therapy, even in people with relatively high levels...
USFDA staff raises efficacy doubts on GSK's lung disease treatment Ruby Khatun Khatun24 July 2018 10:00 AM ISTU.S. Food and Drug Administration staff reviewers have raised doubts over the effectiveness of GlaxoSmithKline Plc’s (GSK) drug Nucala in treating a...
China vaccine scandal ripples through domestic market, threatens global push Ruby Khatun Khatun24 July 2018 9:45 AM ISTSHANGHAI: A vaccine scandal in China, which has hit a nerve in the country and prompted quick reactions from leaders in Beijing, is sending ripples...
AstraZeneca to stockpile drugs as Brexit safety net Ruby Khatun Khatun24 July 2018 9:30 AM ISTLONDON: AstraZeneca is increasing stockpiles of those medicines in Britain and Europe that could be affected by Brexit by around 20 percent, in...
